1. Home
  2. RGCO vs CRBU Comparison

RGCO vs CRBU Comparison

Compare RGCO & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

N/A

Current Price

$22.74

Market Cap

233.9M

Sector

Utilities

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$1.99

Market Cap

203.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGCO
CRBU
Founded
1912
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
203.9M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
RGCO
CRBU
Price
$22.74
$1.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.00
AVG Volume (30 Days)
8.2K
1.2M
Earning Date
05-07-2026
06-08-2026
Dividend Yield
3.87%
N/A
EPS Growth
11.21
3.64
EPS
0.47
N/A
Revenue
$95,334,212.00
N/A
Revenue This Year
$8.27
N/A
Revenue Next Year
$3.36
$10.48
P/E Ratio
$47.96
N/A
Revenue Growth
12.63
N/A
52 Week Low
$19.68
$0.66
52 Week High
$23.82
$3.53

Technical Indicators

Market Signals
Indicator
RGCO
CRBU
Relative Strength Index (RSI) 62.21 59.91
Support Level $20.49 $1.71
Resistance Level $23.01 $2.11
Average True Range (ATR) 0.57 0.16
MACD 0.12 0.00
Stochastic Oscillator 92.89 66.67

Price Performance

Historical Comparison
RGCO
CRBU

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: